Andere talen EMVision Medical Devices Ltd

Aandelen

EMV

AU0000028375

Vertraagde tijd Australian S.E. Andere beurzen 05:37:57 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,17 ^AUD	-1,36%		-1,80%	+28,61%

29/02	EMVision Medical Devices krijgt een investering van 15,28 miljoen Australische dollar van Keysight Technologies	MT
29/02	EMVision Medical Devices Ltd rapporteert resultaten voor het halfjaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

EMVision Medical Devices Secures AU$15.28 Million Investment from Keysight Technologies	29/02
EMVision Medical Devices Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	29/02
EMVision Sets Sight on US With US$10M Keysight Investment	28/02
EMVision Medical Devices Ltd announced that it expects to receive AUD 15.281174 million in funding from Keysight Technologies, Inc.	28/02
EMVision Medical Devices Secures Nearly AU$3 Million R&D Tax Rebate for Fiscal Year 2023	18/12
EMVision Medical Devices Enrolls 150 Patients for Brain Scanner Trials	28/11
EMVision Medical Devices Assembles 28-Antenna Prototype of Helmet Scanner; Shares Jump 12%	24-10-23
Emvision Reports Positive Interim Results from Stage II Trial of Stroke Detection Algorithm	11-10-23
EMVision Medical Devices Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	30-08-23
Emvision Medical Begins Enrollment at Second Site for Portable Brain Scanner Stage Two Trial	29-06-23
Emvision Medical Devices Limited Receives $1.75 Million Manufacturing Grant Award	13-06-23
Emvision Medical Devices Appoints CEO	31-05-23
EMVision Medical Devices Ltd. Announces Leadership Transition, Effective July 1, 2023	31-05-23
EMVision Medical Devices Ltd. Appoints Forough Khandan as Chief Technology Officer	31-05-23
EVision Medical Devices Begins Stage 2 Clinical Trial for Portable Brain Scanner	29-05-23
EMVision Medical Devices Limited Appoints Professor Alan Coulthard to Clinical Advisory Board	13-03-23
EMVision Medical Devices Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	27-02-23
EMVision Medical Devices Completes Enrollment for Stage 1 Clinical Trial for Brain Scanning Technology	21-02-23
EMVision Medical Devices Ltd Completes Clinical Trial Stage 1 Enrolment	20-02-23
EMVision Medical Devices Advances Clinical Trial for Portable Brain Scan Device, Secures Grant Funding Milestone	26-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen EMVision Medical Devices Ltd

Aandelen

EMV

AU0000028375

Andere talen

Filters